Enter assignee name

EPO Patents = 2

Forward Citations = 32

Loading Chart...

10 inventors (with patents filed for the assignee):

William Winston (7 out of 18 patents)

Daniel Hicklin (7 out of 22 patents)

Nels P Nielson (7 out of 12 patents)

4. Cynthia Seidel-Dugan (5 out of 16 patents)

5. Jose-Andres Salmeron-Garcia (4 out of 4 patents)

6. Heather R Brodkin (4 out of 14 patents)

7. Cynthia S Dugan (2 out of 2 patents)

8. Philipp Steiner (1 out of 6 patents)

9. Sonja Kleffel (1 out of 1 patent)

10. Christopher James Nirschl (1 out of 1 patent)

11. Cynthia Seidel-dugan (0 patent)

12. Heather Brodkin (0 patent)

7 patents: Sort by Forward Citations

1. 11590224 - Anti-TIGIT antigen-binding proteins and methods of uses thereof (2023-02-28),

2. 11453720 - Anti-TIGIT antigen-binding proteins and methods of use thereof (2022-09-27),

3. 11186644 - Anti-neuropilin antigen-binding proteins and methods of use thereof (2021-11-30),

4. 10988545 - Anti-GITR antigen-binding proteins and methods of use thereof (2021-04-27),

5. 10507244 - Anti-TIGIT antigen-binding proteins and methods of use thereof (2019-12-17),

6. 10227413 - Anti-neuropilin antigen-binding proteins and methods of use thereof (2019-03-12),

7. 9713641 - Anti-TIGIT antigen-binding proteins and methods of use thereof (2017-07-25),

Potenza Therapeutics is a biotechnology company focused on developing novel cancer immunotherapies. The company leverages its proprietary platforms to discover and develop new treatments that harness the power of the immune system to fight cancer. Potenza's innovative approach aims to address the limitations of current cancer therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#267 in Cambridge, MA

#2,243 in Massachusetts

#38,834 in US

Cambridge, MA, United States of America

Potenza Therapeutics, Inc.